Despite today's CRL on Rolapitant IV, Wedbush analyst David Nierengarten is raising his price target on Tesaro (NASDAQ: TSRO) price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE